Диссертация (1139900), страница 21
Текст из файла (страница 21)
178. – P. 1075-1082.198. Tuberculosis and HTV-coinfection / E. Valadas [et al.] // 8 th European conferenceon clinical aspects and treatment of HIV-infections. – Athens, 2001. – Vol. 182. –P. 329.131199. Tuberculosis-associated immune 5.
Reconstitution inflammatory syndrome: casedefinitions for use in resource-limited settings / G. Meintjes [et al.] // Lancet.Infect. Dis. – 2008. – Vol. 8. – P. 516-523.200. Tuberculosis immune reconstitution inflammatory syndrome in countries withlimited resources / R. Colebunders [et al.] // Int. J. Tuberc. Lung Dis. – 2006. –Vol. 10, № 9. – P.
946-953.201. Tuberculosis infection in HIV-infected Indian patients / M. Vajpayee [et al.] //AIDS Patient Care. – 2004. – Vol. 18, № 4. – P. 209-213.202. Tuberculosis risk varies with the duration of HIV infection: a prospective study ofEuropean drug users with known date of HIV seroconversion / L. Van Asten[et al.] // AIDS.
– 2003. – Vol. 17, № 8. – P.1201-1208.203. Williams, B.G. Antiretroviral drugs for tuberculosis control in the era ofHIV/AIDS / B.G. Williams, C. Dye // Science. – 2003. – Vol. 301. – P. 1535-1537.204. http://bankpatentov.ru/node/194729205. http://www.who.int/tb/publications/global_report/ru/ [Электронныйресурс]/ВОЗ. – 2015. – Режим доступа: http://www.who.int/tb/publications/global_report/gtbr2015_execsummary_ru.pdf?ua=1..
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
